CME: Perioperative Hemodynamic Optimization Using Goal Directed Therapy
ACCREDITATION EXPIRED: November 25, 2015
Activity Description / Statement of Need:
In this online CME self-learning program:
The use of goal-directed therapy both improves outcomes and reduces costs in the perioperative setting. Dr. Cannesson discusses current practices and makes suggestions for practice improvements. He describes the challenges associated with peri-operative fluid management globally and shares the experience of UC – Irvine in the development of its “surgical home”.
The role of hemodynamic monitoring has direct implications, both in the near- and long-term, in predicting patient outcomes after surgery. The employment of hemodynamic monitoring and goal-directed therapy in a protocolized fashion improves post-operative complications within a given window of opportunity; this program examines the components of successful monitoring techniques and discusses how they may be applied to the overall surgical patient population. Employing findings both from a retrospective study he conducted and those of a wide-ranging meta-analysis, Dr. Manecke illustrates the association between peri-operative goal-directed therapy and post-operative complications and mortality.
Dr. Gan discusses the consequences of goal directed therapy and incorporating it into an enhanced recovery after surgery (ERAS) protocol. Minimally invasive methods to monitor cardiac output are also discussed, Dr. Gan suggests that the concept of individualized GDT is an integral component in the optimization of perioperative fluid management for high-risk surgical patients.
Target Audience:
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by Educational Grants from Edwards Lifesciences
Release Date: November 25, 2013 -- Expiration Date: November 25, 2015
Faculty: Gerald Manecke Jr., MD -- Maxime Cannesson, MD -- Tong (TJ) Gan, MB, FRCA, FFARCSI
Agenda
Learning Objectives
By the end of the session the participant will be able to:
- Describe the relationship between hyper-, hypo-, and normovolemia in terms of anticipated adverse clinical outcomes in the surgical setting
- Describe the effect of goal-directed therapy on peri-operative morbidity and mortality.
- Describe the frequency with which peri-operative complications occur
- Describe the financial impact of peri-operative complications
Accreditation
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Faculty Disclosure: Dr. Cannesson, MD, PhD discloses that he is a consultant for Edwards Lifesciences, Masimo, and Covidien. Dr. Makecke, MD discloses that he is a consultant for Edwards Lifesciences. Dr. Gan, MD discloses that heis a consultant for Edwards Lifesciences and receiving research support from Baxter, Cheetah Medical, Covidien, Durect, Eisai, Edwards Life Science, Fresenius-Kabi and Hospira.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences.
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of medical devices.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.